A research proposal on the relationship between investment in medical devices and hospital performance by Figueiredo, José António & Eiriz, Vasco
 - 1 - 
A research proposal on the relationship 
between investment in medical devices 
and hospital performance 
José Figueiredo and Vasco Eiriz 
Abstract — This paper aims to propose a research on the impact of medical devices on hospital performance. New medical 
devices, from typical magnetic resonance and ultrasound technology to more modern and rare technologies like transplant 
surgery or orthopedic devices, are very expensive and, in some cases, are in a test phase. These new medical devices allow 
hospitals to offer new or enhanced services. New medical devices provide more patients to hospitals, a higher level of usage 
rate and additional revenues. But sometimes, they will not bring superior performance due to its poor usage. This paper 
proposes to investigate the relationship between investment in medical devices and hospital performance in the Portuguese 
hospital sector using data collected from secondary and primary sources. Some of the expected difficulties in implementing 
this research are also discussed. 
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1 INTRODUCTION 
echnological innovation exists in many 
parts of a hospital. According to Djellal 
and Gallouj (2005), services provided by 
hospitals are basically medical and nursery 
treatment, nevertheless, hotel/catering and 
managerial services are included as part of 
the output of a hospital. In this case, one can 
identify many sources of technological 
innovation, from new pharmaceuticals to 
therapeutic diagnosis or even intangible soft 
innovation, like new therapeutic techniques. 
Lovelock et al. (1999, p. 314) referred to the 
core service provided by a healthcare 
insurance as including a personal advisory 
team, a health information line and immediate 
access to private healthcare treatment. The 
extended service could include inpatient and 
outpatient treatment, use of private 
ambulances, home nursing and, among others, 
overseas medical care. 
Given this wide range of healthcare 
services, therefore they may have different 
sources of innovation, whether in its core or in 
the supplementary part of the service. The 
focus of this research will be on hospitals, in 
particular the ones with inpatient and outpatient 
treatment, regardless the type of ownership 
(state owned or private) and their main 
objective (profit or non-profit oriented). This 
study is being carried out in Portugal, where 
there are different types of hospital 
organisations, even tough, a major part of 
hospitals belongs to the public national 
healthcare service. 
This paper is organized as follows. Section 
2 defines the type of technological innovation 
that it will be evaluated. Section 3 proposes a 
framework to evaluate performance, while 
section 4 discusses the proposed relationship 
between investment in medical devices and 
hospital performance. Finally, before 
concluding, section 5 will explore the main 
methodological choices. 
2 TECHNOLOGICAL INNOVATION IN MEDICAL 
DEVICES 
Jonsson et al. (2002, p. 218) have pointed out 
that health technology may be “broadly 
defined to include the drugs, devices, medical 
and surgical procedures used in health care, 
as well as measures for prevention and 
rehabilitation of disease, and the 
organisational and support systems in which 
health care is provided”. 
This research will focus on medical devices 
(e. g., magnetic resonance, x-rays equipment, 
ventilators and chemotherapy equipment). 
There are two main reasons for this choice: i) 
medical devices represent an important part of 
hospitals' investments in new technologies; ii) 
T
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the increasing importance of this type of 
technologies in healthcare services, especially 
for diagnosis purpose. 
According to Siebert et al. (2002, p. 735), 
the European Directive 93/42/EEC defines a 
medical device as: “….any instrument, 
apparatus, appliance, material or other article, 
whether used alone or in combination, 
including the software necessary for its proper 
application intended by the manufacturer to 
be used for human beings for the purpose of: 
a) diagnosis, prevention, monitoring, 
treatment or alleviation of disease; b) 
diagnosis, monitoring, treatment or alleviation 
of or compensation for an injury or handicap; 
c) investigation, replacement or modification 
of the anatomy or of a physiological process; 
d) control of conception. And which does not 
achieve its principal intended action in or on 
the human body by pharmacological, 
immunological or metabolic means, but which 
may be assisted in its functions by such 
means”. 
All medical devices available in European 
countries bear a CE marking, as Siebert et al. 
(2002, p. 735) referred to “as proof they meet 
the essential requirements for safety and 
performance laid down in the relevant 
directive”. But unlike new pharmaceuticals, 
medical devices will depend much more from 
the relationship with its users or its 
surrounding procedure. 
The reimbursement process of costs of a 
new technology involves a complex evaluation 
in order to compare the clinical effectiveness 
or costs, compared with existing medical 
alternatives. The process of Health 
Technology Assessment (HTA) which is 
applied in the European Union (plus 
Switzerland), obliges manufacturers to 
support rational decisions, in order to stop the 
support of a product with well known 
technologies, cost effectiveness or clinical 
effectiveness irrelevant compared with 
existing products. 
According to Siebert et al. (2002) the study 
design to prove the economic evidence is not 
a pacific issue in the medical devices industry. 
In pharmaceuticals it is common to use 
randomized controlled trials, which is almost 
impossible to carry out in some medical 
devices, because sometimes the number of 
patients to be targeted is so small, that it is 
statistically irrelevant. Black (1996) pointed 
out that randomized controlled trials and 
observation could be two complementary 
approaches. 
The economic evidence based almost 
exclusively on costs is not a unique solution 
because sometimes the life-enhancing and 
life saving perspective are very important too. 
In this case, it is important to develop the 
evaluation of the new medical device in a joint 
effort base, like the one developed by the 
medical devices industry with healthcare 
professionals and patients' associations. 
Another important aspect to take into 
account is the international comparison of 
results. The results of the research could not 
be seen for a specific centre, neither for a 
specific country, but at a much more wide 
view (this is one of the major objectives of the 
HTA approach). 
The National Institute for Clinical 
Excellence (NICE) was established to advise 
the National Healthcare Service (NHS) in 
England and Wales on the appropriate usage 
of health technology. Here, too, helath 
technology can include pharmaceuticals, 
medical devices, diagnostic techniques, 
clinical procedures and health promotion. 
The process of evaluation by NICE is 
referred to by Taylor (2002): “for each 
technology appraisal, NICE invites relevant 
manufacturers and sponsors, national 
professional groups, and national patient 
groups to submit evidence”. The author 
referred to some specific characteristics such 
as complications and, among others, results. 
The focus of the HTA approach on doctors 
and manufacturers is criticized by Cookson 
and Maynard (2000) as creating barriers to 
optimal HTA. The authors categorized these 
barriers in two types: demand-side and 
supply-side barriers. 
Demand-side barriers: 
 doctors incentives to provide the best 
care for their own patients, regardless 
the costs and consequences for 
others; 
 "expert" incentives to avoid 
accountability and to prevent the 
production and use of evidence from 
challenging decisions. 
Supply–side barriers: 
 provider incentives in order to supply 
selective evidence to market their 
products; 
 researcher incentives to supply 
interesting rather than integrated and 
focused research. 
Cookson and Maynard (2000, p. 644) also 
argued that doctors remain as “The Expert 
Judges of Need”, which sometimes will focus 
exclusively on clinical effectiveness, rather 
than to articulate equity goals and equity 
efficiency trade-offs. 
At this point, this research will focus on 
existing technologies, in particular medical 
devices changing rapidly, as referred to by 
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Herzlinger (1999). 
We will discuss in Section 5, the 
methodological steps of the research, but in 
the meantime we will propose a list of medical 
devices that will be evaluated in the hospital 
field, as presented in Table 1. The choices 
that we have done, regards: i) the most 
important equipments in diagnosis area; ii) 
equipments that are subject of incremental 
innovation are much more adequate to be 
studied; iii) the equipments selected are 
available in a bigger part of the hospital 
network. 
TABLE 1 
MEDICAL DEVICES TO BE EVALUATED 
Medical device Date of 
Mammography 
equipment 
 
 
 
 
New equipment 
introduced after 
2000 
Ultra sound 
Resonance magnetic 
Computed axial 
Tomography 
Defibrillator 
Ventilator 
New devices for 
healing fractures 
Angiography 
equipment 
Radiography 
Nuclear medicine / 
PET 
Source: Authors. 
3 PERFORMANCE 
Services are mainly intangible and therefore 
service performance is basically intangible. 
Kennerley and Neely (2002) focused on 
performance as a major issue in business 
research and also a key point to 
management. Nevertheless, according to 
these authors, the measures to evaluate 
performance are not evolving, which could be 
a drawback in an era of great changes. Profits 
and cost evolution are not yet fundamental 
measures of performance in healthcare. The 
mission, the objectives and the external 
competitive environmental could be also a 
target of performance evaluation. Also, as 
referred to by Kennerley and Neely (2002, p. 
1241), “the performance measurement 
system itself consists of three interrelated 
elements (individual measures, the set of 
measures and the enabling infrastructure)”. 
The focus of this paper is on hospitals and 
the need to find a common framework to 
evaluate the performance of different types of 
hospitals. Yap et al. (2005) developed a 
research in Canada (Ontario), concerning the 
evaluation of performance of different types of 
healthcare organizations, from acute and 
non–acute hospitals (one mental care hospital 
and one chronic care hospital) to teaching and 
community hospitals, large and small ones. 
Their methodology was based on the 
balanced scorecard developed by Kaplan and 
Norton (1992). The research aimed to indicate 
the performance of multiple hospitals or 
healthcare organisations in the dimensions of 
learning and growth, internal business 
processes, customer and financial 
performance. 
Even tough, as referred to by Yap et al. 
(2005, p. 252), this evaluation system raises a 
critical question: "the critical question is, to 
what extent do the strategies of the payer or 
hospital system resemble the strategies of the 
healthcare organisation’s individual hospital, 
which supports the use of a standardized 
scorecard for the hospital’s specific 
management needs?” 
From this research in Canada, we found a 
common base with the context of our 
research: i) funding restraints; ii) managers of 
hospital system are increasingly concerning 
about measuring and managing 
organisational performance in an attempt to 
remain focused on delivering high quality 
patient care, while maintaining expenditures 
within global budgets that are centrally 
established. 
Some aspects could trigger poor 
performance from hospitals like over 
utilization of some services due to provider 
decisions, the mismanagement of sicker 
patients moving from a physician to another 
one, and repeating some tests or 
examinations (Davis, 2004). 
Figure 1 presents several inputs and 
outputs of hospitals. This research intends to 
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evaluate the impact of medical devices inputs 
in the output of the hospital. 
The evaluation of hospital performance that 
we intend to research is specifically focused 
on medical devices, which means that we will 
neglect some key aspects related to hospital 
performance, like the type of technical 
operators, their experience and specific 
knowledge. For instance, if a hospital has a 
Resonance Magnetic (RM) probably will have 
a higher number of examinations and a 
superior number of consultations, which at an 
ultimate step could mean that this hospital 
could have a higher rate of bed occupancy. 
 
FIGURE 1 
INPUTS AND OUTPUTS OF THE HOSPITAL 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
 
 
 
 
Source: Authors 
We will neglect also other aspects such as 
demographic evolution around the hospital 
area and the type of buying decision of 
equipments. Normally, the decision process of 
buying such type of equipment is centralized 
(at the Department of Health, in the case of 
the National Health Service), which could 
mean that the administration of the hospital, 
which knows better the needs of the 
organisation, could not be listened. 
In the next section, we will develop in more 
detail the relationship to be tested. 
4 THE PROPOSED RELATIONSHIP 
The research to be carried out will be 
developed in hospitals with characteristics 
presented in Table 2. 
TABLE 2 
TYPE OF HOSPITALS TO BE RESEARCHED 
Hospital variables Characteristics 
Ownership Public (government 
owned); private for-
profit; private non for-
profit; public – private 
partnerships. 
Inpatient and 
outpatient hospitals 
All included 
Specific illness 
hospitals 
Excluded (mental 
illness hospital, 
chronic illness hospital 
and maternity 
hospitals) 
Size of beds All included 
Teaching hospitals All included 
Geographical area Portugal (including 
Madeira and Azores 
islands) 
Source: Authors 
After the selection of the hospitals to 
research, we will try to evaluate from primary 
and secondary sources, which ones invest 
more in new medical devices and the possible 
relationship with some specific variables of 
hospital performance, as proposed in Figure 
2. 
FIGURE 2 
RELATIONSHIP TO BE TESTED 
 
    
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Source: Authors 
The importance of diagnosis tools in 
Inputs: 
- Beds. 
- Medical devices. 
- Transportation kits. 
- Building facilities. 
- Pharmaceutical 
solutions. 
- Specialized 
personal. 
- Others. 
Outputs: 
- Number of 
surgeries. 
- Number of 
tests. 
- Number of 
examinations. 
- Level of 
facilities 
occupancy. 
- Number of 
urgencies. 
- Number of 
consultations. 
- Others. 
Number of 
medical devices 
per hospital, 
since 2000: 
- RM 
- CAT 
- Mammography 
equipment 
- Nuclear 
Medicine / PET 
- Ultrasound 
equipment 
- Angiography 
equipment 
- Others 
Hospitals level of 
activity, since 2000: 
- Growth of patients 
leaving inpatient 
situation. 
- Growth of 
surgeries 
accomplished 
- Growth of external 
consultations 
- Growth of urgency 
episodes 
- Growth of tests and 
examinations 
 
 
Hypothesis: hospitals that invest more in new 
medical devices equipment will have a superior 
performance. 
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healthcare is increasing for several reasons: 
to decrease the level of doctor’s doubts; to 
improve doctor’s decision; and, among others, 
to serve as a defense for doctors. 
On the other hand, for some hospitals the 
lack of some specific type of medical device 
could be a driver to lose many patients, and 
trough this, to a decrease of its level of 
occupancy, number of examinations and 
consultations. 
According to the Comissão para Avaliação 
dos Hospitais Sociedade Anónima (2006), it 
does not exist in Portugal a star ranking 
system to evaluate different hospitals, similar 
to the National Health System, from The 
United Kingdom. The British system is based 
on several items, such as: i) waiting time for a 
surgery; ii) percentage of cancelled surgeries; 
iii) waiting time in hospital urgency; and 
among others, iv) percentage of patients with 
a cancer waiting for a consultation for a period 
of more than 15 days. 
The Comissão para Avaliação dos 
Hospitais Sociedade Anónima (2006), 
indicates that Unidade de Missão (which is a 
body dependent from the Department of 
Health) is the unique entity to have an 
efficiency index, even tough with an excessive 
focus on economic issues, instead of a mix 
between clinical and economical items. 
In order to test the feasibility of the 
proposed relationship, it will be necessary to 
have some precautions. These issues will be 
analysed in the next section. 
5 METHODOLOGY 
As referred by Comissão para Avaliação 
dos Hospitais Sociedade Anónima (2006), “we 
consider necessary to have an annual 
performance indicator of hospitals, which 
could reflect a clinical and an economic view”. 
This means, that Portugal does not have an 
information system that collects, monitors and 
analyses all statistical information, to evaluate 
the performance of the National Healthcare 
System. This will oblige us to take a special 
precaution in the development of the 
research, otherwise we will miss some 
important data (for instance: different 
information available in different 
organisations, difficulty on the creation of the 
same concepts for different organizations and, 
among others, a lack of routine in providing 
and working real data). 
As the universe of hospitals is so 
heterogeneous (belonging to the state 
government, with different types of 
management, private hospitals, with a profit as 
an objective and non-profit ones), we think the 
best entity to answer to our questions is each 
Administration of each hospital. 
In a universe of 135 Portuguese hospitals, it 
is difficult to manage a common mailing task 
and afterwards to face a possible low level of 
answer. Based on an official list from the 
Department of Health we will send a 
questionnaire to the board of the hospital. 
Some formal steps will be needed (e. g., formal 
letter explaining the objective of the research). 
We will take also some informal steps, like 
using e-mail, and phone and fax tools, in order 
to have a higher response rate. 
Possibly, some data will be possible to get 
from secondary sources, but this will not 
invalidate the general questionnaire that we 
have in mind to do. Secondary data will serve to 
confirm, for instance, some concepts and 
terminology. 
As it was mentioned before, this research 
proposal has some constrains and limitations. 
For example, if a hospital will buy new medical 
equipment in 2000, how long will it take to put 
the new equipment in a sufficient level of 
efficiency? This hospital will put the new medical 
equipment working possibly in 2000, but the 
necessary knowledge from the different 
operators of the equipment (doctors, nurses and 
other technicians) will take some months or 
more. This raises a new question: how long will 
we wait to try to relate the two data sources (the 
new medical equipment installation and the 
related higher level of service)? 
6 CONCLUSION 
Performance is definitely a major issue in 
private organizations and also in typical state 
government institutions, like hospitals. If a 
shareholder wants a superior return on 
investment, the government or the taxpayer 
wants better efficiency from public investments. 
Healthcare treats human beings. Even tough, 
healthcare is a major industry all over the world, 
and therefore it needs to have a special 
attention in the way the allocation of resources 
and its spending is done. 
If we want to analyze all the hospitals and try 
to evaluate their performance, we will face a 
huge task, due to: i) different types of ownership; 
ii) the participation of different stakeholders in 
the hospital; iii) the complexity of dealing with 
human beings; and, among others, iv) the 
enormous number of variables that influences 
hospital performance (from demography 
variables to catering, type of services, etc.). 
Medical devices are one of the major sources 
of spending in healthcare services, representing 
roughly 6% of total spending in healthcare in the 
European Union. But, medical devices 
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equipment is also one of the major sources of 
increased quality of life. These two assumptions 
have taken us to evaluate the investment in new 
medical devices and looking to the immediate 
answer of the market, instead of a common 
evaluation of return on investment. 
Nevertheless, investments in new technology 
are always risky. Sometimes a hospital could 
buy new medical device equipment that will not 
bring additional outputs, because of a lack of 
knowledge in its use and, as a consequence, 
the offer of a poor service. Finally, some 
decisions to buy new medical devices in 
Portuguese hospitals are supported mainly by 
clinician directors, which could not be seen 
sometimes as an efficiency-oriented decision, 
but a pure clinical decision. 
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